Prostaglandin D2 (PG-D2), Urine - Prostaglandins are fatty acids derived from arachidonic acid metabolism. They are closely related to the Thromboxanes and Leukotrienes. Prostaglandin D2 is derived mainly from Prostaglandin H2, and is metabolized to Dihydroketo Prostaglandin D2. Prostaglandin D2 is excreted directly into the urine. The sites of highest Prostaglandin D2 activity are the brain, spinal cord, intestines, and stomach. Prostaglandin D2 is the major Prostaglandin produced by uterine tissue. Prostaglandin D2 is a potent bronchoconstrictor, neuromodulator, and anti-antithrombin agent. It also stimulates the secretion of Pancreatic Glucagon. Prostaglandin D2 has been found to have an anti- metastatic effect on many malignant tumor cells. Prostaglandin D2 production and circulating levels are drastically suppressed by aspirin and indomethacin.
Prostaglandin D2 (PGD2) is a bioactive lipid compound that plays a significant role in various physiological and pathological processes within the human body. It belongs to the family of prostaglandins, which are a group of physiologically active lipid compounds having diverse hormone-like effects in animals. PGD2 itself is produced primarily by mast cells, which are cells involved in the immune response, and it is derived from arachidonic acid through the action of the enzyme prostaglandin D synthase. This compound has several important roles, including the mediation of allergic responses and inflammation. In the context of allergies, PGD2 can cause symptoms such as bronchoconstriction and vasodilation. It's also involved in the regulation of sleep-wake cycles and acts as a neuromodulator in the brain.
In clinical and research settings, measuring the levels of PGD2 in urine can provide valuable insights into various disease states, particularly those related to allergic reactions and inflammatory conditions. Urinary levels of PGD2 metabolites, such as 9α,11β-prostaglandin F2, are often used as a non-invasive biomarker for systemic mast cell activation. This is particularly useful in conditions like systemic mastocytosis or anaphylaxis, where elevated levels of PGD2 metabolites in the urine can indicate increased mast cell activity. Additionally, research into PGD2 has expanded into areas such as cancer, cardiovascular diseases, and neurodegenerative disorders, where its role and potential as a therapeutic target are being investigated. The measurement of PGD2 levels in urine is an important tool in both diagnosis and monitoring of these conditions, providing a non-invasive method to assess the involvement and activity of prostaglandins in various pathological states.
Prostaglandin D2 (PG D2), Urine
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →
All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.